Skip to main content
. 2022 May 12;2022:9051229. doi: 10.1155/2022/9051229

Figure 1.

Figure 1

The correlation between the expression of TSPAN9 and HCC prognosis. (a) Representative results of immunohistochemical staining. (b) Log-rank test of survival time in patients with HCC. (c and d) The Kaplan-Meier plotter on the analysis to OS (c) and DFS (d) of TSPAN9 in HCC patients. (e) In HCC, the enrichment of pathways negatively correlated with the expression level of TSPAN9.